Tampa General Hospital is the First Health System in Florida to Adopt the LIBERTY® Endovascular Robotic System
Microbot Medical®’s LIBERTY® Endovascular Robotic System Continues to Expand Market Visibility; Being Featured at an Industry Leading Innovation Conference
Microbot Medical (NASDAQ:MBOT) was upgraded by analysts at B.Riley Securit to a "strong-buy" rating.
Microbot Medical®’s LIBERTY® Endovascular Robotic System Highlighted at a Leading Vascular Disease Management Conference
Microbot Medical (NASDAQ:MBOT) is now covered by analysts at B. Riley Securities. They set a "buy" rating and a $5.00 price target on the stock.